Tag: Biotechnology

Bruker
Global, United States

Bruker Acquires Electron Microscopy Company Nion

High-end STEM Technology Expands Bruker’s Portfolio for Materials Science Research BILLERICA, Mass.–(BUSINESS WIRE)–Bruker today announced that it has acquired Nion, a privately-held company that develops and manufactures innovative high-end scanning transmission electron microscopes (STEM). Nion was the first company to introduce aberration correction for STEM instruments with ultra-high stability for highest resolution images, and Nion is the world leader in ultra-high energy and spatial resolution electron … Continue reading Bruker Acquires Electron Microscopy Company Nion

Impact Newswire
Star Therapeutics
Global, United States

Star Therapeutics Appoints Scott Robertson, MBA, as Chief Business Officer and Chief Financial Officer

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Star Therapeutics, a biotechnology company interrogating novel biology to develop life-changing therapies, today announced the appointment of Scott Robertson, MBA, as Chief Business Officer and Chief Financial Officer. Mr. Robertson brings more than twenty years of experience with corporate strategy, business operations, capital raising and M&A. “I’m very excited to join the Star Therapeutics team at a time of great momentum … Continue reading Star Therapeutics Appoints Scott Robertson, MBA, as Chief Business Officer and Chief Financial Officer

Impact Newswire
1910 GENETICS
Global, United States

1910 Genetics Appoints Dr. Shaan C. Gandhi as Independent Board Director

Dr. Gandhi is VP and Head of Strategic Partnerships for Pfizer Ignite and will bring clinical, strategic and financial leadership to biotech’s board BOSTON–(BUSINESS WIRE)–1910 Genetics, the only biotech advancing small and large molecule drug discovery with an automated, multimodal AI platform, today announced the appointment of Shaan C. Gandhi, MD, DPhil, to its board of directors. Gandhi joins as an independent board director and … Continue reading 1910 Genetics Appoints Dr. Shaan C. Gandhi as Independent Board Director

Impact Newswire
Amide Technologies
Global, United States

Amide Technologies Announces Complex Peptide Manufacturing Platform, Raises $16.5M to Expedite Frontier Drug Discovery

Spun out of MIT, Amide partners with biopharmas to accelerate peptide drug development – shortening synthesis to days instead of months – with peptides 3x longer than existing methods CAMBRIDGE, Mass.–(BUSINESS WIRE)–Amide Technologies, a biotech that synthesizes challenging peptides, announced today that it has begun commercializing its novel peptide manufacturing platform. The company also announced it has raised $16.5 million in total funding to date, … Continue reading Amide Technologies Announces Complex Peptide Manufacturing Platform, Raises $16.5M to Expedite Frontier Drug Discovery

Impact Newswire
Abcuro
Global, United States

Abcuro Appoints Mark Pruzanski, M.D., as Chairman of its Board of Directors

December 06, 2023 07:00 AM Eastern Standard Time NEWTON, Mass.–(BUSINESS WIRE)–Abcuro, Inc., a clinical-stage biotechnology company developing therapies for the treatment of autoimmune diseases and cancer through precise modulation of cytotoxic T and NK cells, today announced the appointment of Mark Pruzanski, M.D., as Chairman of its Board of Directors. Dr. Pruzanski brings more than 30 years of experience as a life sciences executive, entrepreneur … Continue reading Abcuro Appoints Mark Pruzanski, M.D., as Chairman of its Board of Directors

Impact Newswire
SILENCE THERAPEUTICS
Global, Untied Kingdom

Silence Therapeutics Strengthens Executive Leadership Team with Key Appointments

Curtis Rambaran, MD, promoted to Chief Medical Officer Marie Wikström Lindholm, PhD, promoted to Chief Scientific Officer December 01, 2023 07:00 AM Eastern Standard Time LONDON–(BUSINESS WIRE)–Silence Therapeutics plc, Nasdaq: SLN (“Silence” or the “Company”), an experienced and innovative biotechnology company committed to transforming people’s lives by silencing diseases through precision engineered medicines, today announced Curtis Rambaran, MD, previously Silence’s Vice President, Head of Clinical … Continue reading Silence Therapeutics Strengthens Executive Leadership Team with Key Appointments

Impact Newswire
MYTOS
Global, Untied Kingdom

Mytos Announces $19M Series A Funding to Automate Human Cell Manufacturing and Further Accelerate Growth

November 30, 2023 08:00 AM Eastern Standard Time LONDON–(BUSINESS WIRE)–Mytos, an innovative leader in automated cell manufacturing, announced today it has closed $19M in Series A financing led by Buckley Ventures, with participation from IQ Capital and Wing VC. “Mytos is revolutionizing cell manufacturing, providing a simple solution that pharma and biotech companies can easily integrate into their research workflow”Post this The funding will accelerate … Continue reading Mytos Announces $19M Series A Funding to Automate Human Cell Manufacturing and Further Accelerate Growth

Impact Newswire
BIOSKRYB GENOMICS
Global, United States

BioSkryb Genomics Appoints Genomics Industry Veteran Ram Laxman as Chief Commercial Officer

Ram Laxman brings executive leadership experience from 10x Genomics, Illumina, and Pacific Biosciences to expand BioSkryb’s international footprint November 29, 2023 09:00 AM Eastern Standard Time DURHAM, N.C.–(BUSINESS WIRE)–BioSkryb Genomics, a company transforming single-cell analysis by enabling the most complete multiomic view of the cellular ecosystem, from discovery to diagnostics, has appointed Ram Laxman, Ph.D., as Chief Commercial Officer. Dr. Laxman will lead sales and … Continue reading BioSkryb Genomics Appoints Genomics Industry Veteran Ram Laxman as Chief Commercial Officer

Impact Newswire